J
Juan C. Hernandez-Prera
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 62
Citations - 1059
Juan C. Hernandez-Prera is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Medicine. The author has an hindex of 12, co-authored 53 publications receiving 547 citations. Previous affiliations of Juan C. Hernandez-Prera include Beth Israel Medical Center & Mount Sinai Health System.
Papers
More filters
Journal ArticleDOI
Staging and grading of oral squamous cell carcinoma: An update.
Alhadi Almangush,Antti Mäkitie,Antti Mäkitie,Asterios Triantafyllou,Remco de Bree,Primož Strojan,Alessandra Rinaldo,Juan C. Hernandez-Prera,Carlos Suárez,Luiz Paulo Kowalski,Alfio Ferlito,Ilmo Leivo +11 more
TL;DR: The various controversies and possible developments of the current staging and grading criteria of OSCC are briefly discussed in this update together with possible applications of artificial intelligence in the context of screening and risk stratification.
Journal ArticleDOI
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
Andrés Coca-Pelaz,Jatin P. Shah,Juan C. Hernandez-Prera,Ronald Ghossein,Juan P. Rodrigo,Dana M. Hartl,Kerry D. Olsen,Ashok R. Shaha,Mark Zafereo,Carlos Suárez,Iain J. Nixon,Gregory W. Randolph,Antti Mäkitie,Luiz Paulo Kowalski,Vincent Vander Poorten,Alvaro Sanabria,Orlando Guntinas-Lichius,Ricard Simo,Peter Zbären,Peter Angelos,Avi Khafif,Alessandra Rinaldo,Alfio Ferlito +22 more
TL;DR: A review of the more aggressive variants of papillary thyroid cancer with respect to main characteristics, histological and molecular features, and the consequences that the knowledge of these variants should have in the treatment of the patients.
Journal ArticleDOI
Changing Epidemiology of Hepatocellular Adenoma in the United States: Review of the Literature
TL;DR: Whereas earlier reports of HCA in the United States described cases exclusively in women exposed to OCPs, there is a trend towards an increase in HCAs reported in men, HCAs in the absence of OCP use, and increased reporting of multiple HCAs, a result of newer OCP formulations and increasing prevalence of obesity.
Journal ArticleDOI
Morphologic features of extrahepatic manifestations of hepatitis C virus infection.
Huaibin M. Ko,Juan C. Hernandez-Prera,Hongfa Zhu,Steven Dikman,Harleen Sidhu,Stephen C. Ward,Swan N. Thung +6 more
TL;DR: The histomorphologic features of HCV-associated processes are highlighted, which are typically characterized by chronic inflammation, immune complex deposition, and immunoproliferative disease in the affected organ.
Journal ArticleDOI
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.
Charles Balabaud,Wesal R. Al-Rabih,Pei-Jer Chen,Kimberley J. Evason,Linda D. Ferrell,Juan C. Hernandez-Prera,Shiu-Feng Huang,Thomas Longerich,Young Nyun Park,Alberto Quaglia,Peter Schirmacher,Christine Sempoux,Swan N. Thung,Michael Torbenson,Aileen Wee,Matthew M. Yeh,Shiou-Hwei Yeh,Brigitte Le Bail,Jessica Zucman-Rossi,Paulette Bioulac-Sage +19 more
TL;DR: If HCA malignant transformation occurs in all HCA subgroups, the risk is by far the highest in the β-catenin-mutated subgroups (b-HCA, b-IHCA), particularly for smaller nodules (<5 cm) in terms of imaging, follow-up, and resection.